why does semaglutide increase heart rate and rate: Understanding the risks GLP-1 Agonists and Heart Rate
Description
GLP-1 therapy shifts patients out of both extremes
A newer finding from Phase 3 data is dysesthesia (skin tingling or sensitivity) affecting about 21% of participants at the highest dose
Large clinical trials and post-marketing surveillance have found no increased thyroid cancer incidence in GLP-1 users
this publication hasn't independently confirmed the reference price or whether it reflects prevailing market pricing
Supply Unlicensed Medicinal Products (Specials)
